Details for New Drug Application (NDA): 018862
✉ Email this page to a colleague
NDA 018862 describes BETATREX, which is a drug marketed by Savage Labs and is included in three NDAs. Additional details are available on the BETATREX profile page.
The generic ingredient in BETATREX is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
The generic ingredient in BETATREX is betamethasone valerate. There are sixty-six drug master file entries for this compound. Fifteen suppliers are listed for this compound. Additional details are available on the betamethasone valerate profile page.
Summary for 018862
| Tradename: | BETATREX |
| Applicant: | Savage Labs |
| Ingredient: | betamethasone valerate |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 018862
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | CREAM;TOPICAL | Strength | EQ 0.1% BASE | ||||
| Approval Date: | Aug 31, 1983 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
